Published Editorials and Industry Updates

Welcome to Perspectives, our blog designed to keep members, oncology stakeholders, and anyone interested in enhancing the care experience for oncology patients informed on critical issues. You’ll hear from thought leaders and learn about the impact and benefits of medically integrated pharmacy, operational insights designed to support you in the day-to-day delivery of care, as well as timely industry issues facing oncology pharmacy professionals.

One Quarter in the Rearview Mirror: A Discussion of DIR Fee Transitions

May 2, 2024

By: NCODA Editorial Team   While the industry continues to work toward greater transparency, the changes to the direct and indirect remuneration (DIR) fees in 2024 have been a significant topic for our member organizations. Over the years, DIR fees have caused confusion and financial surprises for pharmacies across the U.S. given implementation and differences […]
read more

Driving Quality Patient Care and Enhancing Outcomes – Asembia 2024

April 30, 2024

Attending Asembia 2024- Access to Pharmacy in Las Vegas? NCODA will be there advancing the discussion on priority topics like patient centered care, cost and accessibility to medication for patients, collaboration and of course the advantages of medically integrated care within the oncology space. On Wednesday, May 1, NCODA founder and Executive Director Michael Reff […]
read more

Equitable Impact of Clinical Pharmacists on Oncology Patient Care

April 18, 2024

Practice interviews and survey results to understand how pharmacists at select medically integrated dispensing (MID) pharmacies help deliver equitable oncology patient care NCODA, in collaboration with Pfizer Oncology, conducted an online survey of its members in summer 2023 to better understand disparities in oncology care for older adults. This survey revealed that most practice sites […]
read more

2024 NCODA International Spring Forum

April 3, 2024

NCODA is looking forward to kicking off the 2024 International Spring Forum in Dallas this afternoon. The Forum, Driving Optimal Strategies for Patient Care in Medically Integrated Oncology, runs April 3-5 and will feature insights and presentations for enhancing coordination and patient outcomes for every member of the integrated care team. The agenda is designed […]
read more

Learnings from the Change Healthcare Shutdown in Delivering Continuous Care

March 14, 2024

NCODA Executive Council Member Lucio N. Gordan of Florida Cancer Specialists & Research Institute Florida Cancer Specialists & Research Institute shares insight and thoughts on the ongoing Change Healthcare issue and the importance of keeping patient care at the forefront. We appreciate all member practices for working diligently to support patients and their needs during […]
read more

Maintaining Patient Coordination at the Pharmacy Level is Essential to Care

February 23, 2024

By: Stacey McCullough, PharmD, Chief Pharmacy Officer at NCODA Medicare patients are some of the heaviest users of our healthcare system and require the most pharmacy support to manage both chronic and episodic health needs. According to the Kaiser Family Foundation analysis of National Health Expenditure data from CMS, Medicare’s contribution to total national health […]
read more


November 20, 2023

The federal Ethics in Patient Referrals Act — more commonly referred to as the Stark Law — prohibits physicians and other healthcare professionals from referring Medicare and Medicaid patients to facilities in which they or their immediate family members have ownership or invested interest.   The law was created to address concerns of “self-referral” policies where […]
read more


November 1, 2023

HOW 5 NCODA PRACTICES WERE EMPOWERED TO TAKE THE NEXT STEP IN IMPROVING PATIENT CARE   By Bill Wimbiscus Oncolytics Today Editor There’s a moment in the life of nearly every oral oncology patient, a moment that can have a profound effect on their treatment outcome.   That moment occurs immediately after the “first fill” of their […]
read more


October 25, 2023

THE QUEST FOR A NEW CANCER DRUG IS NOT FOR THE FAINT OF HEART  By  Brett Williams, PhD  With 10 new FDA approvals in the second half of 2019 alone, the toolbox of oral oncolytics is continuously expanding.   These new approvals present patients and providers alike with new therapeutic options, but also bring the […]
read more


October 24, 2023

RACIAL EXCLUSION IN CANCER CLINICAL TRIALS HAS LEFT BEHIND THE POPULATIONS MOST IN NEED OF TREATMENT  By Porscha Johnson, PharmD, CPGx  While research has led to profound advancements in cancer treatments — including antibody-drug conjugates and immunotherapy, as well as the utilization of pharmacogenomics to aim for precision medicine through gene-drug matched targeted therapy — […]
read more


October 24, 2023

By Amy Niles, MBA  Employer-sponsored health plans use alternative funding programs (AFPs) as a way to lower their costs by forcing patients who need specialty medications to search for funding elsewhere.   This often leads to patients delaying or going without their critical treatment that should have been covered by their health plan from the start.   […]
read more


October 23, 2023

NCODA partners with Prime Therapeutics to offer accreditation for its new MIP program    Since 2016, “Going Beyond the First Fill” has been NCODA’s credo and the primary focus of its Mission to create a patient-centered, safe, high-quality, comprehensive program to meet the needs of the oncology community.  And now, thanks to a unique opportunity that […]
read more


Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast


Member Resources



Member Login



Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit


P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization